Home » Topics » Briefs » Other news to note

Other news to note
RSS

Antineoplastic aromatase inhibitor from Yamanouchi shows potential for hormone-related illnesses

Oct. 11, 1996

Fujisawa pursues new indications for tacrolimus

Oct. 11, 1996

Celecoxib development status in Japan

Oct. 11, 1996

Yamanouchi awaits marketing approval for Farom

Oct. 11, 1996

Fujisawa antibiotic awaiting MHW approval

Oct. 11, 1996

Troglitazone and Warner-Lambert/Sankyo joint venture

Oct. 4, 1996

Company Profile: Vion

Oct. 4, 1996

Company Profile: PathoGenesis

Oct. 4, 1996

Elan and Cytogen form new company for cancer therapeutics and diagnostics

Oct. 4, 1996

CRO merger completed

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...